ELVN

ELVN

USD

Enliven Therapeutics Inc. Common Stock

$17.630-0.540 (-2.972%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$18.170

High

$18.310

Low

$16.800

Volume

0.26M

Company Fundamentals

Market Cap

1.0B

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

0.53M

Exchange

NMS

Currency

USD

52-Week Range

Low $13.3Current $17.630High $29.38

Related News

PR Newswire

Enliven Therapeutics Announces Clinical Data in CML Patients with Atypical Fusion Transcripts at ASH 2025 Annual Meeting

Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and...

View more
Enliven Therapeutics Announces Clinical Data in CML Patients with Atypical Fusion Transcripts at ASH 2025 Annual Meeting